SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is surging as traders cheer robust financial results and a massive revenue forecast for the coming year, leading to widespread discussion of a potential short squeeze. Many investors are pointing to the stock's significant valuation discount relative to AI sector peers and are actively debating whether to hold for a major re-rating or lock in gains as the price tests key resistance levels.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is attracting intense community attention following record-breaking revenue growth and raised financial guidance that has significantly outperformed expectations. Investors are actively debating the stock's potential for a short squeeze, fueled by substantial backlog increases and aggressive expansion, though some remain cautious due to persistent EBITDA losses and historical volatility.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumble is trending as investor interest surges following recent earnings and the integration of Northern Data assets, with the community closely tracking a significant rise in short interest that many believe is setting the stage for a potential squeeze. Bullish sentiment is heavily focused on the company's pivot toward AI infrastructure, specifically the monetization of its expanding GPU fleet and unmonetized power capacity through the Quake AI platform.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is seeing significant investor enthusiasm driven by a record revenue report that beat expectations and an upward revision to full-year guidance. The community is actively discussing the company's strong government backing and commercial momentum, with many traders framing recent price action as a bear trap and pushing for a move toward higher resistance levels.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is experiencing intense volatility and heavy retail debate ahead of its upcoming earnings report, with community members clashing over whether the stock is a long-term growth opportunity or a target for continued short-selling pressure. Sentiment remains polarized as traders weigh record backlog expansion against ongoing cash burn and dilution concerns.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco is seeing intense community debate following a significant post-earnings selloff, with many investors viewing the drop as a market overreaction and a buying opportunity given the company's strong AI-driven growth and raised guidance. While some participants express frustration over margin concerns and the influence of trading algorithms, bulls are highlighting institutional accumulation and consensus price target increases as reasons for long-term optimism.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is experiencing a surge in retail interest and institutional accumulation, with investors heavily focused on the company's progress toward a Q4 BLA submission for its lead prostate cancer immunotherapy. The community is actively discussing recent positive clinical data, the strengthening of the company's cash runway, and the anticipation of further institutional re-rating as the company approaches key regulatory milestones.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is trending as investors closely monitor a 90-day milestone window for a key anchor tenant announcement and the appointment of a new CEO. While the company has secured significant power infrastructure and landed major turbines, community sentiment remains highly polarized between those betting on long-term value from the AI data center buildout and skeptics concerned about execution risk and capital structure.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is rallying as the community reacts to its key supply partner, Lumilens, emerging from stealth with a multi-billion-dollar hyperscaler deal and a $5.5B valuation. Investors are intensely focused on the production ramp of POETs optical engines and speculating that the combination of high short interest and upcoming earnings catalysts could trigger significant upside momentum.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is seeing high investor activity following positive second-quarter financial results and the announcement of a new multi-year commercial supply agreement with DaVita. While the community is actively debating the significance of the DaVita contract and the company's ability to maintain upward momentum post-TDAPA, the bullish sentiment remains strong as traders watch for further adoption milestones.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GRI is moving lower on persistent dilution concerns, with traders citing a $250 million shelf registration and a fresh $60 million ATM facility as overhangs. The company's estimated cash runway of roughly 4.5-7 months and a fully diluted share count that far exceeds the visible float reinforce fears of heavy share issuance and a potential reverse split.

GRI Bio Reports Positive Study Results For Chronic Lung Disease, But Stock Slumps 20% — What Happened?

Equity

The company said that the new data indicate that GRI-0621 may support the regeneration of lung tissue.

GRI Bio Drug Shows Promising Lung Function Recovery In Patients With Thickened Lungs

GRI Bio shared promising data from a Phase 2a trial for idiopathic pulmonary fibrosis, a chronic lung disease with no known cause.read more...

Barclays lifts Kojamo, I-RES ratings; cuts Grainger on low yield

This account has been verified as an official GRI representative.

Verified Account

GRI Bio

GRI Bio, Inc. engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. It focuses on its lead program, GRI-0621, an inhibitor of type 1 invariant Natural Killer T (iNKT) cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis. The company was founded in May 2009 and is headquartered in La Jolla, CA.

GRI Bio Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

GRIGRI Bio Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest GRI News